Chronic Kidney Disease Trial, Recruiting NCT05963126 Sponsor: University Hospital Ostrava Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT05963126
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have high blood pressure (hypertension) and are currently taking at least one medication to treat it

Who may not be able to join:

  • People who have diabetes of any type, indicated by certain blood sugar or HbA1c test results above specific levels
  • People whose high blood pressure is not well controlled, meaning office blood pressure readings are above 180/110 mmHg or similar readings are shown on a 24-hour blood pressure monitoring test
  • People who are currently receiving dialysis or another form of kidney replacement therapy
  • People who have a rheumatic or autoimmune condition such as rheumatoid arthritis, lupus, scleroderma, dermatomyositis, or inflammatory bowel disease, or who have tested positive on certain autoimmune screening blood tests (ANA/ENA)
  • People with an active infection, indicated by a CRP blood test result above 50 mg/l
  • People with serious liver disease, such as cirrhosis, or certain liver enzyme levels above a specified threshold on blood tests
  • People who have a terminal illness with no available curative treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zdeněk Ramík, MD, University Hospital Ostrava

Phone: 0042059737

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Ostrava
Registry
ClinicalTrials.gov
Start date
1 July 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Glomerular filtration rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov